See All Slides - tctmd.com

Slides

Presentation

Racial Disparity with On-Treatment Platelet Reactivity in Patients Undergoing PCI

Presenter: L.K. Pendyala

June 05, 2013

Presentation

Stent Placement vs. Balloon Angioplasty for Obstructive Lesions in the Popliteal Artery

Presenter: Aljoscha Rastan

June 05, 2013

Presentation

An Economic Evaluation of Percutaneous LAA Occlusion

Presenter: Sheldon M. Singh

June 04, 2013

Presentation

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Presenter: T. Palmerini

June 04, 2013

Presentation

Heart Failure (HF) Complicating Non-ST-Segment Elevation ACS

Presenter: Bahit, MC

June 03, 2013

Presentation

What is the Best Initial Management Strategy for Stable Ischemic Heart Disease?

Presenter: 218868|Judith Hochman

May 31, 2013

Presentation EuroPCR 2013

One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study

Presenter: 13956|Raul Moreno

May 31, 2013

Presentation EuroPCR 2013

Clinical evidence in catheter-based renal sympathetic denervation - building the data

Presenter: 161082|Joachim Schofer

May 31, 2013

Presentation EuroPCR 2013

First Report of One-Year Outcomes of the REPRISE I Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System

Presenter: 203171|Ian Meredith

May 31, 2013

Presentation EuroPCR 2013

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Presenter: 203171|Ian Meredith

May 31, 2013

Advertisement

Slides

Racial Disparity with On-Treatment Platelet Reactivity in Patients Undergoing PCI

Stent Placement vs. Balloon Angioplasty for Obstructive Lesions in the Popliteal Artery

An Economic Evaluation of Percutaneous LAA Occlusion

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Heart Failure (HF) Complicating Non-ST-Segment Elevation ACS

What is the Best Initial Management Strategy for Stable Ischemic Heart Disease?

One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study

Clinical evidence in catheter-based renal sympathetic denervation - building the data

First Report of One-Year Outcomes of the REPRISE I Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content